New forms of dog CD80 and CD86 transcripts that encode secreted b7 molecules

Immunogenetics

Volumn 50, Issue 5-6, 1999, Pages 349-353

  Yang, Shumin ^a   Sim, Gek Kee ^a  

^a HESKA CORPORATION   (United States)

Author keywords

CD80; CD86; Costimulatory molecules; Dog; Soluble B7

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; HLA B7 ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; DOG; EXON; GENE ISOLATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; HYDROPHOBICITY; INTRON; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 0032761161     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050612     Document Type: Article

References (15)

1. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C (1993) B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76-79
2. Borriello F, Freeman GJ, Edelhoff S, Disteche CM, Nadler LM, Sharpe AH (1994) Characterization of the murine B7-1 genomic locus reveals an additional exon encoding an alternative cytoplasmic domain and a chromosomal location of chromosome 16, band B5. J Immunol 153:5038-5048
3. Borriello F, Oliveros J, Freeman, GJ, Nadler LM, Sharpe AH (1995) Differential expression of alternate mB7-2 transcripts. J Immunol 155:5490-5497
4. Chambers CA, Allison JP (1999) Costimulatory regulation of T cell function. Curr Opin Cell Biol 11:203-210
5. Davis TA, Craighead N, Williams AJ, Scadron A, June CH, Lee KP (1996) Primary porcine endothelial cells express membrane-bound B7-2 (CD86) and a soluble factor that co-stimulate cyclosporin A-resistant and CD28-dependent human T- cell proliferation. Int Immunol 8:1099-1111
6. Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM (1989) B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 143:2714-2722
7. Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou L-J, White M, Fingeroth JD, Gribben JG, Nadler LM (1991) Structure, expression, and T-cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med 174:625-631
8. Freeman GJ, Borriello F, Hodes RJ, Reiser H, Gribben JG, Ng JW, Kim J, Goldberg JM, Hathcock K, Laszlo G, Lombard LA, Wang S, Gray GS, Nadler LM, Sharpe AH (1993a) Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T-cell proliferation and interleukin 2 production. J Exp Med 178:2185-2192
9. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA, Lombard LA, Gray GS, Nadler LM (1993b) Cloning of B7- 2:a CTLA-4 counter-receptor that costimulates human T-cell proliferation. Science 262:909-911
10. Guo Y, Wu Y, Zhao M, Kong X-P, Liu Y (1995) Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain. J Exp Med 181:1345-1355
11. Inobe M, Linsley PS, Ledbetter JA, Nagai Y, Tamakoshi M, Uede T (1994) Identification of an alternatively spliced form of the murine homologue of B7. Biochem Biophys Res Commun 200:443-449
12. Jellis CL, Wang SS, Rennert P, Borriello F, Sharpe AH, Green NR, Gray GS (1995) Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86). Immunogenetics 42:85-89
13. McHugh RS, Ratnoff WD, Gilmartin R, Sell KW, Selvaraj P (1998) Detection of a soluble form of B7-1 (CD80) in synovial fluid from patients with arthritis using monoclonal antibodies against distinct epitopes of human B7-1. Clin Immunol Immunopathol 87:50-59
14. Selvakumar A, Mohanraj BK, Eddy RL, Shows TB, White PC, Dupont B (1992) Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7. Immunogenetics 36:175-181
15. Selvakumar A, White PC, Dupont B (1993) Genomic organization of the mouse B-lymphocyte activation antigen B7. Immunogenetics 38:292-295